Daymark Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Daymark Wealth Partners's FBT Position: Q2 2026 in Review
Daymark Wealth Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 6.6% in Q2 2026, selling an estimated $478K and leaving 31,616 shares worth $7.84M. The position accounts for 0.19% of the portfolio, ranked #99.
Daymark Wealth Partners first reported a position in FBT in Q4 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Daymark Wealth Partners held 31,616 shares of First Trust NYSE Arca Biotechnology Index Fund worth $7.84M as of Q2 2026.
- Daymark Wealth Partners sold 2,220 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $478K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.19% of Daymark Wealth Partners's portfolio in Q2 2026, its #99 holding.
- Daymark Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2022 and has held it in 15 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.